Comparison of the Immune Effects of an mRNA Vaccine and a Subunit Vaccine against Herpes Zoster Administered by Different Injection Methods

Previous studies have shown that the herpes zoster subunit vaccine Shingrix™ performs well in clinical trials. However, the key ingredient in its adjuvant, QS21, is extracted from rare plants in South America, so vaccine production is limited. Compared with subunit vaccines, mRNA vaccines have the a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Kangyang, Cao, Han, Luan, Ning, Wang, Yunfei, Hu, Jingping, Liu, Cunbao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223669/
https://www.ncbi.nlm.nih.gov/pubmed/37243107
http://dx.doi.org/10.3390/vaccines11051003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223669/
https://www.ncbi.nlm.nih.gov/pubmed/37243107
http://dx.doi.org/10.3390/vaccines11051003

Ejemplares similares